Home/Filings/4/0001214659-24-008874
4//SEC Filing

Wargacki Stephen 4

Accession 0001214659-24-008874

CIK 0001398733other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 1:40 PM ET

Size

5.0 KB

Accession

0001214659-24-008874

Insider Transaction Report

Form 4
Period: 2024-05-10
Wargacki Stephen
Chief Science Officer
Transactions
  • Award

    Common Stock

    2024-05-10+10,000267,963 total
Footnotes (1)
  • [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001960165

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 1:40 PM ET
Size
5.0 KB